OneMedNet Corp (ONMD) · Insider trading
What OneMedNet's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$4.19M
3 insiders, 14 trades
Sold, 12 months
$321,349
2 insiders, 0% under a plan
Net, 12 months
+$3.87M
bought less sold
Latest filing
2026-10-13
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Kosasa ThomasDirector, 10% owner | $3.90M | – | 11 | 2026-10-07 | 1,983,573 |
| Yu JeffreyDirector, Chief Medical Officer, 10% owner | $2.25M | – | 24 | 2026-10-09 | 896,840 |
| Green AaronDirector, Chief Executive Officer | $51,665 | $266,059 | 7 | 2026-09-24 | 247,971 |
| Golden Robert LawrenceDirector, Chief Financial Officer | – | $55,290 | 3 | 2026-09-21 | 91,291 |
| Casaburi EricDirector | $32,056 | – | 3 | 2025-10-15 | 65,475 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-09 | Yu JeffreyDirector, Chief Medical Officer, 10% owner | Buy | 45,126 | 5.54 | $249,998 | 896,840 | Form 4 |
| 2026-10-07 | Kosasa ThomasDirector, 10% owner | Buy | 129,758 | 5.78 | $750,001 | 1,983,573 | Form 4 |
| 2026-09-24 | Green AaronDirector, Chief Executive Officer | Sale | 1,667 | 6.48 | $10,802 | 247,971 | Form 4 |
| 2026-09-22 | Green AaronDirector, Chief Executive Officer | Sale | 5,000 | 7.39 | $36,960 | 249,638 | Form 4 |
| 2026-09-21 | Golden Robert LawrenceDirector, Chief Financial Officer | Sale | 3,000 | 6.63 | $19,890 | 91,291 | Form 4 |
| 2026-09-15 | Golden Robert LawrenceDirector, Chief Financial Officer | Sale | 3,000 | 6.30 | $18,900 | 94,291 | Form 4 |
| 2026-09-14 | Golden Robert LawrenceDirector, Chief Financial Officer | Sale | 2,500 | 6.60 | $16,500 | 97,291 | Form 4 |
| 2026-09-10 | Yu JeffreyDirector, Chief Medical Officer, 10% owner | Buy | 142,857 | 0.63 | $90,000 | 8,923,267 | Form 4 |
| 2026-07-30 | Kosasa ThomasDirector, 10% owner | Buy | 1,449,275 | 0.69 | $1,000,000 | 18,538,150 | Form 4 |
| 2026-06-23 | Yu JeffreyDirector, Chief Medical Officer, 10% owner | Buy | 158,730 | 0.63 | $100,000 | 8,780,410 | Form 4 |
| 2026-06-23 | Green AaronDirector, Chief Executive Officer | Buy | 36,650 | 0.57 | $20,890 | 1,896,375 | Form 4 |
| 2026-06-16 | Yu JeffreyDirector, Chief Medical Officer, 10% owner | Buy | 172,414 | 0.58 | $100,000 | 8,621,680 | Form 4 |
| 2026-06-15 | Green AaronDirector, Chief Executive Officer | Buy | 18,702 | 0.54 | $10,099 | 1,859,725 | Form 4 |
| 2026-06-12 | Green AaronDirector, Chief Executive Officer | Buy | 36,920 | 0.56 | $20,675 | 1,841,023 | Form 4 |
| 2026-06-12 | Kosasa ThomasDirector, 10% owner | Buy | 158,730 | 0.63 | $100,000 | 17,088,874 | Form 4 |
| 2026-05-18 | Kosasa ThomasDirector, 10% owner | Buy | 268,817 | 0.93 | $250,000 | 16,930,144 | Form 4 |
| 2026-04-23 | Kosasa ThomasDirector, 10% owner | Buy | 280,898 | 0.89 | $249,999 | 16,661,327 | Form 4 |
| 2026-04-01 | Yu JeffreyDirector, Chief Medical Officer, 10% owner | Buy | 903,614 | 0.83 | $750,000 | 8,229,837 | Form 4 |
| 2026-02-06 | Kosasa ThomasDirector, 10% owner | Buy | 595,238 | 0.84 | $500,000 | 16,380,429 | Form 4 |
| 2025-11-18 | Green AaronDirector, Chief Executive Officer | Sale | 61,555 | 1.20 | $73,866 | 1,804,103 | Form 4 |
| 2025-10-22 | Green AaronDirector, Chief Executive Officer | Sale | 64,767 | 2.23 | $144,430 | 1,865,658 | Form 4 |
| 2025-10-15 | Casaburi EricDirector | Buy | 10,000 | 3.05 | $30,500 | 65,475 | Form 4 |
| 2025-09-25 | Yu JeffreyDirector, Chief Medical Officer | Buy | 1,250 | 1.03 | $1,288 | 7,081,223 | Form 4 |
| 2025-09-24 | Kosasa ThomasDirector | Buy | 6,000 | 0.93 | $5,580 | 15,740,191 | Form 4 |
| 2025-09-24 | Yu JeffreyDirector, Chief Medical Officer | Buy | 17,200 | 1.02 | $17,544 | 7,079,973 | Form 4 |
| 2025-09-23 | Yu JeffreyDirector, Chief Medical Officer | Buy | 5,700 | 0.93 | $5,301 | 7,062,773 | Form 4 |
| 2025-09-22 | Yu JeffreyDirector, Chief Medical Officer | Buy | 400 | 0.95 | $380 | 7,057,073 | Form 4 |
| 2025-09-19 | Yu JeffreyDirector, Chief Medical Officer | Buy | 1,250 | 0.89 | $1,112 | 7,056,673 | Form 4 |
| 2025-09-18 | Yu JeffreyDirector, Chief Medical Officer | Buy | 700 | 0.91 | $637 | 7,055,423 | Form 4 |
| 2025-09-05 | Yu JeffreyDirector, Chief Medical Officer | Buy | 2,100 | 0.86 | $1,806 | 7,054,723 | Form 4 |
| 2025-09-04 | Yu JeffreyDirector, Chief Medical Officer | Buy | 11,810 | 0.87 | $10,275 | 7,052,623 | Form 4 |
| 2025-09-03 | Yu JeffreyDirector, Chief Medical Officer | Buy | 11,670 | 0.81 | $9,453 | 7,040,813 | Form 4 |
| 2025-09-02 | Yu JeffreyDirector, Chief Medical Officer | Buy | 24,319 | 0.85 | $20,671 | 7,029,143 | Form 4 |
| 2025-08-29 | Kosasa ThomasDirector | Buy | 581,395 | 0.86 | $500,000 | 15,734,191 | Form 4 |
| 2025-08-29 | Yu JeffreyDirector, Chief Medical Officer | Buy | 10,890 | 0.82 | $8,930 | 7,004,824 | Form 4 |
| 2025-08-28 | Yu JeffreyDirector, Chief Medical Officer | Buy | 17,000 | 0.80 | $13,600 | 6,993,934 | Form 4 |
| 2025-08-27 | Yu JeffreyDirector, Chief Medical Officer | Buy | 21,374 | 0.69 | $14,748 | 6,976,934 | Form 4 |
| 2025-08-26 | Yu JeffreyDirector, Chief Medical Officer | Buy | 173,350 | 0.69 | $119,611 | 6,955,560 | Form 4 |
| 2025-08-25 | Yu JeffreyDirector, Chief Medical Officer | Buy | 13,300 | 0.75 | $9,975 | 6,782,210 | Form 4 |
| 2025-08-21 | Yu JeffreyDirector, Chief Medical Officer | Buy | 15,000 | 0.77 | $11,550 | 6,768,910 | Form 4 |
8 more
| 2025-08-19 | Yu JeffreyDirector, Chief Medical Officer | Buy | 16,500 | 0.77 | $12,705 | 6,753,910 | Form 4 |
| 2025-06-20 | Kosasa ThomasDirector | Buy | 1,190,476 | 0.42 | $500,000 | 15,152,796 | Form 4 |
| 2025-06-20 | Yu JeffreyDirector, Chief Medical Officer | Buy | 1,666,666 | 0.42 | $700,000 | 6,737,410 | Form 4 |
| 2025-06-16 | Kosasa ThomasDirector | Buy | 55,000 | 0.38 | $20,900 | 8,480,824 | Form 4 |
| 2025-04-21 | Kosasa ThomasDirector | Buy | 47,000 | 0.49 | $23,030 | 8,425,824 | Form 4 |
| 2024-12-18 | Yu JeffreyDirector, Chief Medical Officer | Buy | 100 | 0.99 | $99 | 2,763,195 | Form 4 |
| 2024-11-20 | Casaburi EricDirector | Buy | 1,300 | 0.87 | $1,131 | 55,475 | Form 4 |
| 2024-11-12 | Casaburi EricDirector | Buy | 500 | 0.85 | $425 | 54,175 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
20 × grant or award6 × conversion
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-06 | Golden Robert LawrenceDirector, Chief Financial Officer | Grant or award A | +35,000 | – | 99,791 | Form 4 |
| 2026-07-06 | Green AaronDirector, Chief Executive Officer | Grant or award A | +65,000 | – | 254,638 | Form 4 |
| 2026-04-01 | Yu JeffreyDirector, Chief Medical Officer, 10% owner | Grant or award A | +219,429 | 0.83 | 8,449,266 | Form 4 |
| 2026-01-01 | Golden Robert LawrenceDirector, Chief Financial Officer | Grant or award A | +10,000 | – | 64,791 | Form 4 |
| 2025-11-26 | Alleyne KennethDirector | Grant or award A | +38,219 | – | 38,219 | Form 4 |
| 2025-11-26 | Clarke JairDirector | Grant or award A | +45,000 | – | 138,485 | Form 4 |
| 2025-11-26 | McCraw Sherry CoonseDirector | Grant or award A | +45,000 | – | 56,342 | Form 4 |
| 2025-11-26 | Zeinfeld Andrew BDirector | Grant or award A | +45,000 | – | 381,525 | Form 4 |
| 2025-11-26 | Casaburi EricDirector | Grant or award A | +45,000 | – | 110,475 | Form 4 |
| 2025-11-26 | Golden Robert LawrenceDirector, Chief Financial Officer | Grant or award A | +45,000 | – | 547,905 | Form 4 |
| 2025-11-26 | Green AaronDirector, Chief Executive Officer | Grant or award A | +45,000 | – | 1,930,425 | Form 4 |
| 2025-11-26 | Kosasa ThomasDirector | Grant or award A | +45,000 | – | 15,785,191 | Form 4 |
| 2025-11-26 | Yu JeffreyDirector, Chief Medical Officer | Grant or award A | +45,000 | – | 7,326,223 | Form 4 |
| 2025-11-24 | Golden Robert LawrenceDirector, Chief Financial Officer | Grant or award A | +300,000 | – | 469,572 | Form 4 |
| 2025-11-24 | Golden Robert LawrenceDirector, Chief Financial Officer | Grant or award A | +33,333 | – | 502,905 | Form 4 |
| 2025-11-24 | Green AaronDirector, Chief Executive Officer | Grant or award A | +1,000,000 | – | 1,885,425 | Form 4 |
| 2025-11-24 | Yu JeffreyDirector, Chief Medical Officer | Grant or award A | +200,000 | – | 7,281,223 | Form 4 |
| 2025-06-19 | Kosasa ThomasDirector | Conversion C | +2,123,424 | 0.75 | 11,097,304 | Form 4 |
| 2025-06-19 | Kosasa ThomasDirector | Conversion C | +2,865,016 | 0.71 | 13,962,320 | Form 4 |
| 2025-06-19 | Yu JeffreyDirector, Chief Medical Officer | Conversion C | +1,828,279 | 0.71 | 5,070,744 | Form 4 |
| 2025-06-17 | Green AaronDirector, Chief Executive Officer | Conversion C | +240,425 | 1.14 | 885,425 | Form 4 |
| 2025-06-17 | Kosasa ThomasDirector | Conversion C | +493,056 | 1.14 | 8,973,880 | Form 4 |
| 2025-06-17 | Yu JeffreyDirector, Chief Medical Officer | Conversion C | +479,270 | 1.14 | 3,242,465 | Form 4 |
| 2025-01-31 | Golden Robert LawrenceDirector, Chief Financial Officer | Grant or award A | +24,272 | – | 169,572 | Form 4 |
| 2025-01-01 | Clarke JairDirector | Grant or award A | +82,143 | – | 93,485 | Form 4 |
| 2025-01-01 | Zeinfeld Andrew BDirector | Grant or award A | +82,143 | – | 336,525 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.